InsidersTradesSigma
Follow the 伟思医疗 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 伟思医疗 has recorded 10 insider filings. Market capitalisation: €4.7bn. The latest transaction was reported on 17 July 2026 (Purchase). Among the most active insiders: 高飞. Every trade is free.
10
Insider Decl.
n/a
Thresholds
€50,463
3 ops.
Buy Volume
€254,456
7 ops.
Sell Volume
18Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,886 of 28,856 companies
61.1
score / 100
Value39
Quality84
FCF yld1.3%
Earn yld3.1%
EV/EBITDA24.3x
ROE9.7%
Gross mgn66%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 July 2026
Declarations10 total
10 of 10 declarations
About 伟思医疗
伟思医疗 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative medical solutions.